Avidity Biosciences vs Lutris Pharma
Avidity Biosciences vs Lutris Pharma, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Avidity Biosciences is on 53/100 and Lutris Pharma on 39/100.
Where each one leads
Avidity Biosciences
- our overall score: 53/100 against 39/100
- funding raised: $495M against $170M
Lutris Pharma
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Avidity Biosciences | Lutris Pharma |
|---|---|---|
| What it is | Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases. | Lutris Pharma is a biotechnology company focused on developing novel therapies for rare genetic diseases. |
| Category | Biotech, Drug Discovery, Genomics, Clinical Trials | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Biotech |
| Founded | 2013 | 2017 |
| Headquarters | San Diego, United States | San Diego, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Avidity Biosciences | Lutris Pharma |
|---|---|---|
| Employees | 445 | Not published |
| Total funding | $495M | $170M |
| Latest round | IPO | Series A |
| LinkedIn followers | 37,705 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Avidity Biosciences | Lutris Pharma |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 39/100 |
| Traction | 60/100 | 40/100 |
| Team | Not published | 60/100 |
| Community | Not published | 15/100 |
| Search visibility | 22/100 | 2/100 |
| Quality | 68/100 | 40/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (37/100) | Not published |
| Domain ratingLink authority, 0-100 | 46/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Avidity Biosciences | Lutris Pharma |
|---|---|---|
| Hosting | Self Managed | Not detected |
| Frameworks | Jquery, Bootstrap | Not detected |
| Analytics | Google Tag Manager | Not detected |
Avidity Biosciences vs Lutris Pharma: common questions
Which is better, Avidity Biosciences or Lutris Pharma?
On our 0-100 score Avidity Biosciences rates higher (53/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Avidity Biosciences and Lutris Pharma compare on the numbers?
Avidity Biosciences leads on our overall score (53/100 against 39/100), funding raised ($495M against $170M).
Read the full Avidity Biosciences review and pricing or the Lutris Pharma review and pricing. You can also browse other Avidity Biosciences alternatives we track.